Skip to main content
OpenTrials
Completed

NCT Number: NCT01573364

Prevalence and Reversibility of Lung Hyperinflation in Asthma

The aim of this observational study is to evaluate the pulmonary hyperinflation and its immediate reversibility to a short acting beta2 agonist test in uncontrolled persistent asthmatic patients with dyspnea.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Asthma Bronchial Diseases Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Respiratory Hypersensitivity Respiratory Tract Diseases

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Laboratoire Chiesi S.A.

Courbevoie, France

About this study

The other objectives are :

  • the evaluation of the hyperinflation defined by an increase of the residual volume (RV),
  • the observation of the relationship between the hyperinflation and the asthma characteristics,
  • the study of the improvement of the functional parameters after a reversibility test
  • the evaluation of the correlation between hyperinflation parameters evolution, chest tightness and dyspnea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient with a diagnosis of uncontrolled persistent asthma (ACT </= 19) or with an MRC score of dyspnea >/= 1
  • Patient requiring a check-up including a pulmonary function test by plethysmography with a reversibility test

Exclusion criteria

  • Patient participating to an other clinical trial or having participated to a clinical trial with medicine in the last 3 months

Sponsors and collaborators

Lead sponsor

Chiesi Farmaceutici S.p.A.

Industry

Registry information

Official study title

Evaluation of the Prevalence and the Reversibility of the Lung Hyperinflation in Uncontrolled Persistent Asthmatic Patients With Dyspnea

Acronym: Dist'air2

Important dates

Study start
2011
Primary completion
2011
Study completion
2012
First posted
Apr 9, 2012
Registry last updated
Apr 9, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.